- Home
- TECH vs FCNCP Comparison
TECH vs FCNCP Comparison
Compare TECH & FCNCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TECH | FCNCP |
|---|---|---|
| Founded | 1976 | N/A |
| Country | United States | United States |
| Employees | N/A | 18141 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2B | N/A |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | TECH | FCNCP |
|---|---|---|
| Price | $72.23 | $20.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $71.82 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 9.7K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | ★ 0.62% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.81 | N/A |
| Revenue | ★ $1,219,635,000.00 | N/A |
| Revenue This Year | $2.49 | N/A |
| Revenue Next Year | $6.40 | N/A |
| P/E Ratio | $88.77 | ★ N/A |
| Revenue Growth | ★ 5.23 | N/A |
| 52 Week Low | $43.20 | $19.67 |
| 52 Week High | $72.37 | $22.86 |
Technical Indicators
Market Signals| Indicator | TECH | FCNCP |
|---|---|---|
| Relative Strength Index (RSI) | 71.72 | 39.48 |
| Support Level | $70.49 | $20.06 |
| Resistance Level | $72.22 | $20.64 |
| Average True Range (ATR) | 0.29 | 0.16 |
| MACD | -0.58 | -0.03 |
| Stochastic Oscillator | 49.18 | 8.00 |
Price Performance
Historical ComparisonAbout TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About FCNCP First Citizens BancShares Inc.
First Citizens is a US regional bank with total assets of around $236 billion as of March 31, 2026. Headquartered in Raleigh, North Carolina, First Citizens' largest markets are North Carolina, South Carolina, and California. The bank has a track record of acquiring troubled banks from the FDIC, such as Silicon Valley Bridge Bank in 2023, which doubled its asset base. First Citizens offers products and services across retail, commercial, wealth management, and railcar leasing. First Citizens derived over 95% of its earnings from banking and less than 5% from railcar leasing in 2025.